Tuesday, 11 October 2011 04:02

Accudial Pharmaceutical, Inc. Acquires Spinformation/Stephen Key Design, LLC.

Accudial Pharmaceutical®, Inc. has acquired Stephen Key Design, LLC. This acquisition expands AccuDial's patent portfolio to over fifty patents for weight based dosing and other extended content rotating labels (ECRL), which adds 75% more labeling space to a container.

"Stephen Key founded the company in 1998 and is a recognized leader in the $63 billion label industry. He will remain at the helm of Stephen Key Design, LLC and continue as a member of AccuDial's Board of Directors," said Bob Terwilliger Chairman and CEO of Accudial Pharmaceutical®.

"In the past thirteen years hundreds of millions of Spinformation® labels have been used on a wide range of products," said Stephen Key. "Spinformation® labels have been used on Rexall Sundown Vitamins, Children's AccuDial pediatric liquid medicines, and Kirkwood Brand products, to name just a few. Spinformation® has partnerships with a number of packaging industry leaders."

Stephen Key will focus with AccuDial on pharmaceutical applications for prescription, over-the-counter, nutritional supplements, injectable vials and vitamins. In addition, Stephen will work with Spinformation® partners to achieve even greater success in the beverage, fruit drink, food industry and other commercial applications.

In addition to weight based dosing, AccuDial's ECRL can be used for PRODUCT LAUNCHES to notify consumers about a new or improved product; DISCOUNT COUPONS on the inner label; QUICK READER (QR) codes can lead consumers to a company's Twitter, Facebook, LinkedIn, YouTube, Flickr, Plaxo, Yelp, FourSquare, Digg, Delicious, StumbleUpon, Whrrl, and MySpace profiles; EASY TO READ TEXT using large font; MULTI-LANGUAGE on the inner label providing directions for multiple markets; ILLUSTRATIONS like Barrier Grid animation to illustrate conditions such as a throbbing pain in the shoulder or lower back; DAILY DOSE and PROGRESS TRACKING for medicine taken multiple times per day.

Beginning October 17, 2011 Children's AccuDial Acetaminophen for Pain & Fever with weight based dosing will be available at Amazon.com, and a number of leading internet drugstore sites. Children's AccuDial Acetaminophen for Pain & Fever will be available in five flavors: cherry, dye-free cherry, bubblegum, strawberry and grape for children between 12 and 95 pounds.

About Accudial Pharmaceutical, Inc.
Accudial Pharmaceutical, Inc. is positioned to change the way medications will be dosed globally. It is the only brand with a patented rotating weight-based dosing system designed to administer over-the-counter medications safely and effectively. Children's AccuDial® is a family of eight analgesic, allergy, cough and cold pediatric medications available in more than 4,300 pharmacies and stores throughout Canada. Children's AccuDial® was recognized as the 2011 Product of the Year Canada in consumer drug packaging, and voted "consumer's choice" for new product innovation. In April, 2011 Children's AccuDial® won The Edison Award in the Consumer Packaged Goods category, The Seal of Approval from PTPA Media Inc. and The Frost & Sullivan New Product Innovation Award for Pediatric Dosing. For up to date information about AccuDial, follow us on Facebook at www.facebook.com/AccuDialPharmaceutical and Twitter at www.twitter.com/AccuDial. For more information about AccuDial®, visit www.accuratedose.com or call 561.429.6886.

About Stephen Key Design, LLC..
Stephen Key Design, LLC., is a licensing company specializing in Spinformation® rotating label technology with specific regard to the packaged goods industry. The rotating label adds 75% more labeling space to a container. The rotating label is offered in a variety of label technologies such as Pressure Sensitive (PS), Cut & Stack, Roll Fed, Shrink Sleeve and Stretch Sleeve. Spinformation awards include TLMI Awards Innovation Winner in Technical Achievement, Pyramid Awards, Award of Excellence in Film Labeling, Food & Drug Packaging News, PACKAGE OF THE YEAR, World Label Association, INNOVATION AWARD, and IOPP AmeriStar Awards, Best of Category (Pharmacy).
 

Read 3376 times Last modified on Tuesday, 31 January 2012 13:17

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

Want more? Visit...

Videos

  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses the launch of ICON's new acquisition of Firecrest at Partnerships in Clinical Trials 2012. Facing the continuing challenge of not only monitoring and…
    Read more...
  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses their exciting new partnership with Roche at Partnerships In Clinical Trials 2012. Medical imaging has always been a strong department within ICON. ICON…
    Read more...
  • ERT- Partnerships 12
    ERT- Partnerships 12 John Blakely, Executive Vice President and Chief Commercial Officer for ERT discusses the new trend in clinical research at Partnerships in Clinical Trials 2012 - the melding of objective and…
    Read more...
  • Chiltern- Partnerships 12
    Chiltern- Partnerships 12 Marcelo Piccirillo, Senior Clinical Research Physician for Chiltern, discusses new trends in gastrointestinal clinical development at Partnerships in Clinical Trials 2012. Current hot spots for clinical development in the field…
    Read more...
  • Blinded Diagnostics - Partnerships 12
    Blinded Diagnostics - Partnerships 12 Paul Savuto, President and CFO, and Steven Karrupan, CEO, from Blinded Diagnostics discuss Point of Care Technology at Partnerships in Clinical Trials 2012. Point of care (or decentralized testing) offers…
    Read more...
  • American Airlines - IQPC 2011
    American Airlines - IQPC 2011 American Airlines has globally launched a passive solutions that gives a new alternative to pharmaceutical manufacturers.
    Read more...

Podcasts